Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer.
about
Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer.Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.Doxorubicin-docetaxel sequential schedule: results of front-line treatment in advanced breast cancer.Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer.Radiation sterilization of anthracycline antibiotics in solid state
P2860
Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@ast
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@en
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@nl
type
label
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@ast
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@en
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@nl
prefLabel
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@ast
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@en
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@nl
P2093
P356
P1433
P1476
Dose-finding study of epidoxor ...... s with advanced breast cancer.
@en
P2093
A Goldhirsch
B Thürlimann
D Crivellari
G Martinelli
P304
P356
10.1023/A:1026437731354
P577
1999-05-01T00:00:00Z